You would think we would have gotten further down the road towards identifying specific inherited genes associated with prostate cancer, but the ugly truth is we're often uncertain about what to look for, let alone test for.
Read MoreA new genetic test has recently become available called Oncotype DX. The test is made by Genomic Health and will now be available at Dr. Samadi's Prostate Cancer Center in New York City. What is Oncotype DX? The Oncotype DX prostate cancer test is a biopsy-based genetic test that can be combined with other measures to predict the aggressiveness of prostate cancer. The test applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions for each individual patient.
Read MoreProstate cancer is the second most common cancer diagnosed in men in the United States, with an estimated 240,000 men being diagnosed every year.
Read More
